Clinical evaluation of vascular normalization induced by recombinant human endostatin in nasopharyngeal carcinoma via dynamic contrast-enhanced ultrasonography

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• WeiKRZhengRSZhangSWLiangZHLiZMChenWQNasopharyngeal carcinoma incidence and mortality in China, 2013Chin J Cancer20173619029122009
   PubMedGoogle Scholar
• ZhangMXLiJShenGPIntensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-upEur J Cancer201551172587259526318726
   PubMed Web of Science ®Google Scholar
• PengGWangTYangKYA prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinomaRadiother Oncol2012104328629322995588
   PubMed Web of Science ®Google Scholar
• AuKHNganRKCNgAWYTreatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)Oral Oncol201877162129362121
   PubMed Web of Science ®Google Scholar
• LeeNYZhangQPfisterDGAddition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialLancet Oncol201213217218022178121
   PubMed Web of Science ®Google Scholar
• WangJSunYLiuYResults of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patientsZhongguo Fei Ai Za Zhi200584283290 Chinese21108883
   PubMedGoogle Scholar
• XuRMaNWangFResults of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancerOnco Targets Ther2013692592923926435
   PubMed Web of Science ®Google Scholar
• CuiCMaoLChiZA phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaMol Ther20132171456146323670576
   PubMed Web of Science ®Google Scholar
• YYLJinFClinical results of recombinant human endostatin combined with chemotherapy and radiation therapy for locally advanced nasopharyngeal carcinoma: a Phase 2 multi-institutional trialInt J Radiat Oncol Biol Phys2016962E378
   Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med197128521118211864938153
   PubMed Web of Science ®Google Scholar
• FentonBMPaoniSFDingIEffect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumorsRadiother Oncol200472222123015297140
   PubMed Web of Science ®Google Scholar
• MaJPulferSLiSChuJReedKGalloJMPharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470Cancer Res200161145491549811454697
   PubMed Web of Science ®Google Scholar
• JainRKNormalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapyNat Med20017998798911533692
   PubMed Web of Science ®Google Scholar
• LinMISessaWCAntiangiogenic therapy: creating a unique “window” of opportunityCancer Cell20046652953115607955
   PubMed Web of Science ®Google Scholar
• ChenDRLinCWangYFWindow of opportunity: A new insight into sequential bevacizumab and paclitaxel in two cases of metastatic triple-negative breast cancerExp Ther Med201510388588826622409
   PubMed Web of Science ®Google Scholar
• VangestelCVan de WieleCVan DammeN(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumabJ Nucl Med201152111786179422045708
   PubMed Web of Science ®Google Scholar
• BatchelorTTSorensenAGdi TomasoEAZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsCancer Cell2007111839517222792
   PubMed Web of Science ®Google Scholar
• LiNZhengDWeiXJinZZhangCLiKEffects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine modelJ Cancer Res Clin Oncol201213871131114422402599
   PubMed Web of Science ®Google Scholar
• PengFXuZWangJRecombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma modelsPLoS One201274e3464622496834
   PubMed Web of Science ®Google Scholar
• LassauNChapototLBenatsouBStandardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques StudyInvest Radiol2012471271171623095862
   PubMed Web of Science ®Google Scholar
• GaoYLiuJJZhuSYYiXThe Diagnostic Accuracy of Ultrasonography versus Endoscopy for Primary Nasopharyngeal CarcinomaPLoS One201496e9967924887439
   PubMed Web of Science ®Google Scholar
• DietrichCFAverkiouMACorreasJMLassauNLeenEPiscagliaFAn EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusionUltraschall Med201233434435122843433
   PubMed Web of Science ®Google Scholar
• KangMWangFLiaoXZhouPWangRIntensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinomaMedicine (Baltimore)20189725e1111829924009
   PubMed Web of Science ®Google Scholar
• GuanYLiAXiaoWThe efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinomaOncotarget2015632339263393426418895
   PubMedGoogle Scholar
• JinTJiangFJinQFPiaoYFChenXZEndostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an UpdateTransl Oncol201811228629129413761
   PubMed Web of Science ®Google Scholar
• WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med1991324118
   PubMed Web of Science ®Google Scholar
• Hernández-AgudoEMondejarTSoto-MontenegroMLMonitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PETMol Oncol201610570471826778791
   PubMed Web of Science ®Google Scholar
• WegnerCSHaugeASimonsenTGGaustadJVAndersenLMKRofstadEKDCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma XenograftsNeoplasia201820773474429886124
   PubMed Web of Science ®Google Scholar
• JiangXDDaiPQiaoYWuJSongDALiSQClinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancerClin Transl Oncol201214643744322634532
   PubMed Web of Science ®Google Scholar
• LeenEAverkiouMArditiMDynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trialsEur Radiol20122271442145022302501
   PubMed Web of Science ®Google Scholar
• WilsonSRBurnsPNMicrobubble-enhanced US in body imaging: what role?Radiology20102571243920851938
   PubMed Web of Science ®Google Scholar
• MoriNMugikuraSTakahashiSQuantitative Analysis of Contrast-Enhanced Ultrasound Imaging in Invasive Breast Cancer: A Novel Technique to Obtain Histopathologic Information of Microvessel DensityUltrasound Med Biol201743360761428041744
   PubMed Web of Science ®Google Scholar
• LiXLiYZhuYFuLLiuPAssociation between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancerOncol Lett20181545643564929556301
   PubMed Web of Science ®Google Scholar